February 2, 2017
Biodesix's GeneStrat liquid biopsy test now includes ROS1 and RET mutations. The test helps physicians make treatment decisions for cancer patients.
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
2970 Wilderness Place, Suite 100 Boulder, CO 80301
© Copyright 2021 Biodesix. All Rights Reserved.